3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Head and Neck Neoplasms
11
Squamous Cell Carcinoma of Head and Neck
4
Fatigue
3
Thyroid Neoplasms
2
Nasopharyngeal Carcinoma
2
Depression
2
Anxiety Disorders
2
Triple Negative Breast Neoplasms
1
Sleep Wake Disorders
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Recurrence
1
Radiation Fibrosis Syndrome
1
Paranasal Sinus Neoplasms
1
Pain
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mucositis
1
Mouth Neoplasms
1
Motor Activity
1
Hypothyroidism
1
Esthesioneuroblastoma, Olfactory
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Breast Neoplasms
1
Accessory Nerve Injuries
1
Abdominal Neoplasms
1
Interventions
Cisplatin
8
Radiotherapy
7
Radiation
4
Injections
3
Fibroblast Growth Factor 7
3
Radiotherapy, Intensity-Modulated
2
RRx-001
2
Propolis
2
Honey
2
Amifostine
2
pegfilgrastim
1
oxycodone-acetaminophen
1
kang-lai-te
1
golotimod
1
cyclohexaneacetic acid
1
brilacidin
1
acetaminophen, hydrocodone drug combination
1
Xylitol
1
Water
1
Vaccinium myrtillus extract
1
Traumeel S
1
Tramadol
1
Thioctic Acid
1
Therapeutics
1
Surgical Procedures, Operative
1
Sucralfate
1
Standard of Care
1
Sodium Chloride
1
Selenomethionine
1
Pain Management
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mucositis
×
Therapeutics
×
Head & Neck
×
Clear all
NCT04046250
2023-08-25
TK112690
Tosk, Inc.
Phase 2
Completed
22 enrolled
10 charts